ArticleVaccines2023

Single-Dose Intranasal Immunisation with Novel Chimeric H1N1 Expressing the Receptor-Binding Domain of SARS-CoV-2 Induces Robust Mucosal Immunity, Tissue-Resident Memory T Cells, and Heterologous Protection in Mice.

Donghong Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.